PainTEQ Expands Leadership Team with New Senior VP of Reimbursement and Market Access

PainTEQ, a fast-growing medical innovation company and the creator of LinQ, a minimally invasive therapy for SI joint (SIJ) dysfunction, announced the appointment of Michael Mydra as its new Senior Vice President (SVP) of Reimbursement & Market Access.

Michael has a successful track record of building health economics with sales strategies, particularly in the healthcare sector. In his new role, Michael will be responsible for expanding patient access to the LinQ procedure through reimbursement and market access.

"Michael's extensive experience in healthcare reimbursement, strategic planning and business development is invaluable to PainTEQ," said Sean LaNeve, PainTEQ's CEO. "We are confident he is the right person to lead our efforts in expanding patient access to LinQ."

Michael joins PainTEQ with more than 20 years of experience in healthcare. He has held various leadership positions at several global healthcare companies, including Boston Scientific.

"I am very fortunate to have the opportunity to join the PainTEQ team," Michael stated. "I look forward to supporting PainTEQ and expanding patient access to its LinQ Stabilization System while making a meaningful difference for patients with SI joint dysfunction."